Spotlight on differentially expressed genes in urinary bladder cancer

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Previous identification of common differentially expressed (DE) genes in bladder cancer (BC).
• In-depth analysis of specific gene groups previously identified as DE in BC.

Purpose of the Study:

• To comprehensively analyze the expression patterns of key DE genes in bladder cancer.
• To investigate the relationships among these genes of interest (GOIs) and their biological functions.
• To identify molecular signatures associated with BC progression and grade.

Main Methods:

• Analysis of 30 human BC tissues and adjacent normal samples using whole genome cDNA microarrays, qRT-PCR, and Western blotting.
• Focused analysis on cell-cycle, DNA repair, apoptosis, signal transduction, angiogenesis, proliferation, invasion, and metastasis-related genes.
• Integration and comparison with public GEO datasets, alongside Gene Ontology (GO) and KEGG pathway analysis.

Main Results:

• Unsupervised clustering clearly distinguished BC samples from controls and stratified tumors by grade and invasiveness.
• Identified and ranked genes with significant differential expression, including notable changes in osteopontin (OPN, SPP1).
• GO and KEGG analyses highlighted the involvement of GOIs in diverse biological mechanisms, with the 'Bladder Cancer' pathway being most significant (p=1.5×10⁻³¹).

Conclusions:

• The study contributes to the identification of molecular signatures in bladder cancer.
• Findings provide deeper insights into the complex molecular mechanisms underlying BC development and progression.
• Further research is warranted to leverage these molecular insights for clinical applications.